European Commissioner Joaquin Almunia‘s final day as competition chief is Friday, when his successor, Margrethe Vestager, will take his place and inherit a slew of high-profile competition cases.
Experts and industry players are all watching Vestager, and reports say her first few weeks will be crucial in determining how she will execute her pro-competition rule.
In an essay written by Cadwalader, Wickersham & Taft lawyers Alec Burnside and Anne MacGregor, the authors argue that while the European Commission’s trend has been a relatively straight path of action, Almunia proved a more outspoken competition chief than others before him.
Experts are now wondering if Vestager will similarly make waves as she takes on some of the biggest competition cases currently pending across the globe.
Those cases, of course, include the longstanding antitrust investigation into Google, its market dominance and the way it displays rivals search results. But Almunia also launched new cases in his final weeks, including a probe of certain EU member states’ tax agreements with foreign companies like Apple and Starbucks that have earned criticism.
Full content: Euractiv and NPR
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan